Authors:
Storb, R
Blume, KG
O'Donnell, MR
Chauncey, T
Forman, SJ
Deeg, HJ
Hu, WW
Appelbaum, FR
Doney, K
Flowers, MED
Sanders, J
Leisenring, W
Citation: R. Storb et al., Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: The experience in fourcenters, BIOL BLOOD, 7(1), 2001, pp. 39-44
Authors:
Bhatia, S
Louie, AD
Bhatia, R
O'Donnell, MR
Fung, H
Kashyap, A
Krishnan, A
Molina, A
Nademanee, A
Niland, JC
Parker, PA
Snyder, DS
Spielberger, R
Stein, A
Forman, SJ
Citation: S. Bhatia et al., Solid cancers after bone marrow transplantation, J CL ONCOL, 19(2), 2001, pp. 464-471
Authors:
Fung, HC
Nademanee, AP
Bhatia, S
Forman, SJ
Citation: Hc. Fung et al., Is there an association between total-body irradiation and secondary acutemyelogenous leukemia/myelodysplastic syndrome in patients with relapsed/refractory Hodgkin's disease treated with autologous stem-cell transplantation?, J CL ONCOL, 19(15), 2001, pp. 3585-3587
Authors:
Khoury, H
Kashyap, A
Adkins, DR
Brown, RA
Miller, G
Vij, R
Westervelt, P
Trinkaus, K
Goodnough, LT
Hayashi, RJ
Parker, P
Forman, SJ
DiPersio, J
Citation: H. Khoury et al., Graft-versus-host disease - Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin, BONE MAR TR, 27(10), 2001, pp. 1059-1064
Authors:
Bensinger, WI
Martin, PJ
Storer, B
Clift, R
Forman, SJ
Negrin, R
Kashyap, A
Flowers, MED
Lilleby, K
Chauncey, TR
Storb, R
Rowley, S
Heimfeld, S
Blume, K
Citation: Wi. Bensinger et al., Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers., N ENG J MED, 344(3), 2001, pp. 175-181
Authors:
Somlo, G
Doroshow, JH
Synold, T
Longmate, J
Reardon, D
Chow, W
Forman, SJ
Leong, LA
Margolin, KA
Morgan, RJ
Raschko, JW
Shibata, SI
Tetef, ML
Yen, Y
Kogut, N
Schriber, J
Alvarnas, J
Citation: G. Somlo et al., High-dose paclitaxel in combination with doxorubicin, cyclophosphamide andperipheral blood progenitor cell rescue in patients with high-risk primaryand responding metastatic breast carcinoma: toxicity profile, relationshipto paclitaxel pharmacokinetics and short-term outcome, BR J CANC, 84(12), 2001, pp. 1591-1598
Authors:
Snyder, DS
Nademanee, AP
O'Donnell, MR
Parker, PM
Stein, AS
Margolin, K
Somlo, G
Molina, A
Spielberger, R
Kashyap, A
Fung, H
Vora, N
Slovak, ML
Niland, J
Palmer, J
Negrin, RS
Amylon, MD
Blume, KG
Forman, SJ
Citation: Ds. Snyder et al., Allogeneic bone marrow transplantation for BCR-ABL positive acute lymphoblastic leukemia, HEMAT BLOOD, 40, 2001, pp. 414-418
Citation: Cc. Shih et al., Ex vivo expansion of transplantable human hematopoietic stem cells: Where do we stand in the year 2000?, J HEMATH ST, 9(5), 2000, pp. 621-628
Authors:
Kashyap, A
Kandeel, F
Yamauchi, D
Palmer, JM
Niland, JC
Molina, A
Fung, H
Bhatia, R
Krishnan, A
Nademanee, A
O'Donnell, MR
Parker, P
Rodriguez, R
Snyder, D
Spielberger, R
Stein, A
Nadler, J
Forman, SJ
Citation: A. Kashyap et al., Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study, BIOL BLOOD, 6(3A), 2000, pp. 344-351
Authors:
Chao, NJ
Snyder, DS
Jain, M
Wong, RM
Niland, JC
Negrin, RS
Long, GD
Hu, WW
Stockerl-Goldstein, KE
Johnston, LJ
Amylon, MD
Tierney, DK
O'Donnell, MR
Nademanee, AP
Parker, P
Stein, A
Molina, A
Fung, H
Kashyap, A
Kohler, S
Spielberger, R
Krishnan, A
Rodriguez, R
Forman, SJ
Blume, KG
Citation: Nj. Chao et al., Equivalence of 2 effective graft-versus-host disease prophylaxis regimens:Results of a prospective double-blind randomized trial, BIOL BLOOD, 6(3), 2000, pp. 254-261
Citation: K. Margolin et Sj. Forman, Immunotherapy with interleukin-2 after hematopoietic cell transplantation for hematologic malignancy, CA J SCI AM, 6, 2000, pp. S33-S38
Authors:
Stein, AS
O'Donnell, MR
Slovak, ML
Nademanee, A
Dagis, A
Schmidt, GM
Parker, PM
Snyder, DS
Smith, EP
Somlo, G
Margolin, KA
Arber, D
Niland, J
Forman, SJ
Citation: As. Stein et al., High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission, LEUKEMIA, 14(7), 2000, pp. 1191-1196
Authors:
Shih, CC
Hu, J
Arber, D
LeBon, T
Forman, SJ
Citation: Cc. Shih et al., Transplantation and growth characteristics of human fetal lymph node in immunodeficient mice, EXP HEMATOL, 28(9), 2000, pp. 1046-1053
Authors:
Andersson, BS
Gajewski, J
Donato, M
Giralt, S
Gian, V
Wingard, J
Tarantolo, S
Fernandez, H
Hu, WW
Blume, K
Kashyap, A
Forman, SJ
Champlin, RE
Citation: Bs. Andersson et al., Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy), BONE MAR TR, 25, 2000, pp. S35-S38
Authors:
Louie, AD
Robison, LL
Bogue, M
Hyde, S
Forman, SJ
Bhatia, S
Citation: Ad. Louie et al., Validation of self-reported complications by bone marrow transplantation survivors, BONE MAR TR, 25(11), 2000, pp. 1191-1196
Authors:
Ahuja, HG
Hong, JM
Aplan, PD
Tcheurekdjian, L
Forman, SJ
Slovak, ML
Citation: Hg. Ahuja et al., t(9;11)(p22;p15) in acute myeloid leukemia results in a fusion between NUP98 and the gene encoding transcriptional coactivators p52 and p75-lens epithelium-derived growth factor (LEDGF), CANCER RES, 60(22), 2000, pp. 6227-6229
Authors:
Molina, A
Krishnan, AY
Nademanee, A
Zabner, R
Sniecinski, I
Zaia, J
Forman, SJ
Citation: A. Molina et al., High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy, CANCER, 89(3), 2000, pp. 680-689
Citation: Cc. Shih et Sj. Forman, Response - Leukemia inhibitory factor does not have a direct effect on theexpansion of transplantable human hematopoietic stern cells, BLOOD, 96(3), 2000, pp. 1200-1201